David Shook - Jan 15, 2025 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer, Head of Research & Development
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Jan 15, 2025
Transactions value $
-$19,004
Form type
4
Date filed
1/17/2025, 05:37 PM
Previous filing
Jan 7, 2025
Next filing
Jun 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Sale -$19K -8.64K -4.33% $2.20 191K Jan 15, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.

Remarks:

Chief Medical Officer, Head of Research & Development